Market Overview:
The global vaccine contract manufacturing market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for vaccines, technological advancements in vaccine manufacturing, and rising public-private investments in vaccine research and development (R&D). Based on type, the fill-finish segment is expected to account for the largest share of the global vaccine contract manufacturing market in 2018. This segment is also projected to grow at a higher CAGR than other segments during the forecast period. The high growth rate of this segment can be attributed to factors such as growing demand for vaccines and technological advancements that have led to an increase in production capacity. Based on application, pharmaceutical companies are expected to account for the largest share of the global vaccine contract manufacturing market in 2018.
Product Definition:
A vaccine contract manufacturing company is a business that manufactures vaccines for other businesses. This can be done through either a licensing agreement or a contract manufacturing agreement. The importance of vaccine contract manufacturing is that it allows businesses to outsource the production of their vaccines, which can save them time and money.
Fill-Finish:
Fill-finish is a technique where the last steps of vaccine production are completed in the manufacturing facility. This includes fill-finish operations for vial and prefilled syringe products, bulk packaging, final labeling & finish coatings, and release testing.
Bulk Product:
Bulk product is a collection of vaccines or viral proteins manufactured in large quantities and used as an alternative to single vaccines for immunization. The vaccine can be used for the production of different types of vaccines such as subunit, conjugate, and recombinant vector. It helps reduce the overall cost by reducing per dose costs which are usually associated with single products.
The global bulk product market size was valued at USD 2.5 billion in 2016.
Application Insights:
Based on application, the market has been segmented into pharmaceutical companies, biotechnology companies and others. The pharmaceutical companies segment dominated the global vaccine contract manufacturing market in 2017 owing to factors such as high usage of vaccines across various therapeutic applications and increasing R&D costs for new drugs.
The biotechnology companies are also anticipated to witness lucrative growth over the forecast period due to rising demand for specialty proteins that are used in a variety of diagnostic tests and medicines. Other than these two major segments, there is also a considerable demand coming from within each of these application industries for vaccine contract manufacturing services. For instance, within the pharmaceutical industry; there is an increased need for immunization against diseases such as influenza due to its high prevalence globally which is driving this industry towards greater heights over other markets where similar services are required but not sufficient enough to meet overall global needs (i.e., Latin America).
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of biopharmaceutical manufacturing facilities, advanced healthcare infrastructure and high R&D expenditure by government and private entities are some factors driving the regional market. Moreover, growing focus on disease prevention through immunization programs is expected to fuel vaccine demand in this region over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to increasing investments by governments as well as foreign companies for setting up production facilities for producing vaccines or other pharmaceutical products at minimal costs.
Growth Factors:
- Increasing demand for vaccines due to rising incidence of infectious diseases
- Growing public-private sector partnerships for vaccine development and manufacturing
- Technological advancements in vaccine manufacturing processes and technologies
- Emergence of new players in the vaccine contract manufacturing market
- Rising focus on cost-effective and quality vaccines
Scope Of The Report
Report Attributes
Report Details
Report Title
Vaccine Contract Manufacturing Market Research Report
By Type
Fill-Finish, Bulk Product
By Application
Pharmaceutical Companies, Biotech Companies, Others
By Companies
Diosynth, Emergent BioSolutions, Goodwin Biotechnology, Bavarian Nordic, Soligenix Inc, Catalent Biologics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Vaccine Contract Manufacturing Market Report Segments:
The global Vaccine Contract Manufacturing market is segmented on the basis of:
Types
Fill-Finish, Bulk Product
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical Companies, Biotech Companies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Diosynth
- Emergent BioSolutions
- Goodwin Biotechnology
- Bavarian Nordic
- Soligenix Inc
- Catalent Biologics
Highlights of The Vaccine Contract Manufacturing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Fill-Finish
- Bulk Product
- By Application:
- Pharmaceutical Companies
- Biotech Companies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Vaccine Contract Manufacturing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Vaccine contract manufacturing is a process by which pharmaceutical companies produce vaccines for the public health sector. This process begins with identifying a need for new vaccines, and then working with suppliers to develop customized vaccine products. Once the specifications are finalized, the manufacturers will begin production of the vaccines using state-of-the-art technology.
Some of the major players in the vaccine contract manufacturing market are Diosynth, Emergent BioSolutions, Goodwin Biotechnology, Bavarian Nordic, Soligenix Inc, Catalent Biologics.
The vaccine contract manufacturing market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Vaccine Contract Manufacturing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Vaccine Contract Manufacturing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Vaccine Contract Manufacturing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Vaccine Contract Manufacturing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Vaccine Contract Manufacturing Market Size & Forecast, 2020-2028
4.5.1 Vaccine Contract Manufacturing Market Size and Y-o-Y Growth
4.5.2 Vaccine Contract Manufacturing Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Fill-Finish
5.2.2 Bulk Product
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Pharmaceutical Companies
6.2.2 Biotech Companies
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Vaccine Contract Manufacturing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Vaccine Contract Manufacturing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Fill-Finish
9.6.2 Bulk Product
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Pharmaceutical Companies
9.10.2 Biotech Companies
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Fill-Finish
10.6.2 Bulk Product
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Pharmaceutical Companies
10.10.2 Biotech Companies
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Fill-Finish
11.6.2 Bulk Product
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Pharmaceutical Companies
11.10.2 Biotech Companies
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Fill-Finish
12.6.2 Bulk Product
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Pharmaceutical Companies
12.10.2 Biotech Companies
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Fill-Finish
13.6.2 Bulk Product
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Pharmaceutical Companies
13.10.2 Biotech Companies
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Vaccine Contract Manufacturing Market: Competitive Dashboard
14.2 Global Vaccine Contract Manufacturing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Diosynth
14.3.2 Emergent BioSolutions
14.3.3 Goodwin Biotechnology
14.3.4 Bavarian Nordic
14.3.5 Soligenix Inc
14.3.6 Catalent Biologics
